These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18288251)

  • 1. The progress on genetic analysis of nasopharyngeal carcinoma.
    Zhou X; Cui J; Macias V; Kajdacsy-Balla AA; Ye H; Wang J; Rao PN
    Comp Funct Genomics; 2007; 2007():57513. PubMed ID: 18288251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic susceptibility to the endemic form of NPC.
    Bei JX; Zuo XY; Liu WS; Guo YM; Zeng YX
    Chin Clin Oncol; 2016 Apr; 5(2):15. PubMed ID: 27121875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells.
    Huang SY; Wu CC; Cheng YJ; Chou SP; Jiang YJ; Chu KC; Tsai CH; Lin SF; Chen JY
    Oncotarget; 2017 Oct; 8(45):78948-78964. PubMed ID: 29108278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational genomics of nasopharyngeal cancer.
    Tsang CM; Lui VWY; Bruce JP; Pugh TJ; Lo KW
    Semin Cancer Biol; 2020 Apr; 61():84-100. PubMed ID: 31521748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasopharyngeal carcinoma: A review of current updates.
    Wu L; Li C; Pan L
    Exp Ther Med; 2018 Apr; 15(4):3687-3692. PubMed ID: 29556258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histocompatibility locus antigens regions contribute to the ethnicity bias of Epstein-Barr virus-associated nasopharyngeal carcinoma in higher-incidence populations.
    Roy Chattopadhyay N; Chakrabarti S; Chatterjee K; Deb Roy S; Kumar Sahu S; Reddy RR; Das P; Bijay Kanrar B; Kumar Das A; Tsering S; Puii Z; Zomawia E; Singh YI; Suryawanshi A; Choudhuri T
    Scand J Immunol; 2019 Oct; 90(4):e12796. PubMed ID: 31145476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
    Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiological factors of nasopharyngeal carcinoma.
    Tsao SW; Yip YL; Tsang CM; Pang PS; Lau VM; Zhang G; Lo KW
    Oral Oncol; 2014 May; 50(5):330-8. PubMed ID: 24630258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial and large-scale case-control studies identify genes associated with nasopharyngeal carcinoma.
    Bei JX; Jia WH; Zeng YX
    Semin Cancer Biol; 2012 Apr; 22(2):96-106. PubMed ID: 22313875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches.
    Lo KW; Chung GT; To KF
    Semin Cancer Biol; 2012 Apr; 22(2):79-86. PubMed ID: 22245473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
    Zhu QY; Kong XW; Sun C; Xie SH; Hildesheim A; Cao SM; Zeng MS
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33268566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma.
    Siak PY; Khoo AS; Leong CO; Hoh BP; Cheah SC
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic landscape of nasopharyngeal carcinoma.
    Dai W; Zheng H; Cheung AK; Lung ML
    Chin Clin Oncol; 2016 Apr; 5(2):16. PubMed ID: 27121876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aetiology of nasopharyngeal carcinoma.
    Chan SH
    Ann Acad Med Singap; 1990 Mar; 19(2):201-7. PubMed ID: 2189340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Epstein-Barr virus infection and nasopharyngeal carcinoma pathogenesis.
    Lin CT
    Ai Zheng; 2009 Aug; 28(8):791-804. PubMed ID: 19664324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enigmatic epidemiology of nasopharyngeal carcinoma.
    Chang ET; Adami HO
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1765-77. PubMed ID: 17035381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis.
    Richardo T; Prattapong P; Ngernsombat C; Wisetyaningsih N; Iizasa H; Yoshiyama H; Janvilisri T
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32872147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
    Hui KF; Chan TF; Yang W; Shen JJ; Lam KP; Kwok H; Sham PC; Tsao SW; Kwong DL; Lung ML; Chiang AKS
    Int J Cancer; 2019 Jun; 144(12):3031-3042. PubMed ID: 30536939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma.
    Hau PM; Lung HL; Wu M; Tsang CM; Wong KL; Mak NK; Lo KW
    Front Oncol; 2020; 10():600. PubMed ID: 32528868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.